• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

astrazeneca

  1. Brilinta post covid

    Anyone think Brilinta will recover post covid?
    • anonymous
    • Thread
    • astrazeneca brilinta
    • Replies: 4
    • Forum: AstraZeneca

  2. Pfizer buying AZ

    boss said he heard something like that :O
    • anonymous
    • Thread
    • astrazeneca layoffs pfizer
    • Replies: 41
    • Forum: AstraZeneca

  3. Alexion acquisition uk clearance

    Do you guys know anything about Alexion acquisition and when the deal is going to close? Looks like UK put a brake on it with antitrust.
    • anonymous
    • Thread
    • alexion astra-zeneca astrazeneca
    • Replies: 2
    • Forum: AstraZeneca

  4. Why is Pascal feeding the press?

    Pascal Soriot, chief executive of AstraZeneca, told the Sunday Times: "We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else. “I can't tell you more because we will publish at some point." In a complicated scenario where...
    • anonymous
    • Thread
    • astrazeneca covid-19
    • Replies: 5
    • Forum: AstraZeneca

  5. Proteostasis Therapeutics stock reached double digits

    After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/
    • anonymous
    • Thread
    • astrazeneca biotech clinical trials cystic fibrosis fda novartis pharma proteostasis therapeutics vertex
    • Replies: 0
    • Forum: Pharma/Biotech Companies - In the News

  6. Will Pfizer buy Amarin?

    There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...
    • anonymous
    • Thread
    • amarin astrazeneca biotech cardiovascular lipitor pfizer pharma reduce-it statin vascepa
    • Replies: 5
    • Forum: Pfizer
Top Bottom
Back